Cargando…
Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
Amphotericin B (AmB), a broad-spectrum polyene antibiotic in the clinic for more than fifty years, remains the gold standard in the treatment of life-threatening invasive fungal infections and visceral leishmaniasis. Due to its poor water solubility and membrane permeability, AmB is conventionally f...
Autores principales: | Faustino, Célia, Pinheiro, Lídia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023008/ https://www.ncbi.nlm.nih.gov/pubmed/31906268 http://dx.doi.org/10.3390/pharmaceutics12010029 |
Ejemplares similares
-
Design of amphotericin B oral formulation for antifungal therapy
por: Liu, Min, et al.
Publicado: (2017) -
Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review
por: Bezerra, Lucas Soares, et al.
Publicado: (2020) -
Protective and antifungal properties of Nanodisk-Amphotericin B over commercially available Amphotericin B()
por: Cho, Do-Yeon, et al.
Publicado: (2017) -
Fingolimod Potentiates the Antifungal Activity of Amphotericin B
por: Wei, Lu-Qi, et al.
Publicado: (2021) -
Lipase-Responsive Amphotericin B Loaded PCL Nanoparticles for Antifungal Therapies
por: Uroro, Evelyn Osehontue, et al.
Publicado: (2022)